Starting from April 7, observed as World Health Day, city-based private hospital MedIndia Hospitals will begin screening ...
High cholesterol is a growing concern for many people, as it increases the risk of heart disease and other health problems.
After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback